Guaifenesin And Dextromethorphan Hbr Tablet, Extended Release
Product Images NDC 63304-106

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Dextromethorphan Hbr (NDC 63304-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-guai-dextro-label (Image 01)

Label for Guaifenesin and Dextromethorphan HBr Extended-Release Tablets, 1200 mg/60 mg, by Sun Pharmaceutical Industries, Inc. The label highlights maximum strength, expectorant and cough suppressant use, 12-hour extended release, and contains 14 tablets. Additional details include dosage form as extended-release tablets and dosing information.*

FDA Label Image

Spl-guai-dextro-label2 (Spl Guai Dextro Label2)

The carton label for Guaifenesin and Dextromethorphan HBr Extended-Release Tablets, 600 mg / 30 mg, by Sun Pharmaceutical Industries, Inc. The label highlights this oral tablet as an expectorant and cough suppressant with 20 extended-release tablets. It emphasizes 12-hour control, cough control, mucus thinning, and extended release. The label includes Drug Facts and usage warnings, storage instructions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.